Mads Hansen

High-Dose Methotrexate-Based Chemotherapy Followed by Consolidating Radiotherapy in Non–AIDS-Related Primary Central Nervous System Lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962

Philip Poortmans, Hanneke C. Kluin‐Nelemans, Hanny Haaxma-Reiche et al. · Journal of Clinical Oncology · 2003 · 331 citations

A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia

Peter Gimsing, Mads Hansen, Lene Meldgaard Knudsen et al. · European Journal Of Haematology · 2008 · 160 citations

Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: A randomized phase II study from the Nordic Lymphoma Group

Eva Kimby, Jesper Jurlander, Christian H. Geisler et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2008 · 62 citations

CHOP Versus Chlorambucil + Prednisolone in Chronic Lymphocytic Leukemia

Mads Hansen, Elo Andersen, Henrik Birgens et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1991 · 43 citations

Hematological Malignancy, Lymphoid Neoplasia, Chronic Lymphocytic Leukemia +15

Effect of Various Doses of Intravenous Polyclonal IgG on in vivo Levels of 12 Pneumococcal Antibodies in Patients with Chronic Lymphocytic Leukaemia and Multiple Myeloma

I. Sklenar, Gerald Schiffman, Viggo Jønsson et al. · Oncology · 1993 · 40 citations

Immunohematology, Immunology, Pathology +19